Tocilizumab for the Treatment of Familial Mediterranean Fever
Tocilizumab for the Treatment of Familial Mediterranean Fever – A randomized, doubleblind, phase II proof of concept study-TOFFIFE - Tocilizumab for the Treatment of Familial Mediterranean Fever Tocilizumab for the Treatment of Familial Mediterranean Fever – A randomized, doubleblind, phase II ...
Adult patients with Familial Mediterranean Fever, who have active disease MedDRA version: 20.0;Level: PT;Classification code 10016207;Term: Familial mediterranean fever;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Adult patients with Familial Mediterranean Fever, who have active disease MedDRA version: 20.0;Level ...